Monday, December 13, 2010
Citing liver damage, Pfizer withdraws Thelin
NEW YORK, N.Y. - Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment